Selected article for: "host immune system and immune response"

Author: Shi, Chong-Shan; Nabar, Neel R.; Huang, Ning-Na; Kehrl, John H.
Title: SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes
  • Document date: 2019_6_5
  • ID: 0fpa1f30_20
    Snippet: Though the exact mechanistic role of ORF8b in SARS-CoV pathogenesis remains unclear, it is well established that the splitting of ORF8 corresponds with the shift from the early to the middle stage of the SARS epidemic, with the majority of affected patients being infected by virus containing the split ORF 36 . Recent advances in mouse models have shown that SARS pathogenesis is driven by high initial virus titers resulting from a late interferon .....
    Document: Though the exact mechanistic role of ORF8b in SARS-CoV pathogenesis remains unclear, it is well established that the splitting of ORF8 corresponds with the shift from the early to the middle stage of the SARS epidemic, with the majority of affected patients being infected by virus containing the split ORF 36 . Recent advances in mouse models have shown that SARS pathogenesis is driven by high initial virus titers resulting from a late interferon response, which drives aberrant recruitment of IMMs and activation of the innate immune response resulting in cytotoxicity 9 . Given the likelihood that ORF8b is evolutionarily adaptive for the virus 10 , it follows that ORF8b may contribute to SARS-CoV pathogenesis by impairing the host interferon response and/or targeting the innate immune system. While the former has been previously shown 13 , here we show that ORF8b activates intracellular stress pathways upon forming insoluble aggregates and directly targets innate immunity by activation of the NLRP3 inflammasome.

    Search related documents:
    Co phrase search for related documents
    • aberrant recruitment and innate immunity: 1, 2
    • aberrant recruitment and interferon response: 1
    • aberrant recruitment and SARS cov: 1, 2, 3, 4
    • affected patient and early shift: 1
    • affected patient and immune response: 1, 2, 3
    • affected patient and SARS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57
    • affected patient and SARS epidemic: 1
    • early shift and immune response: 1, 2, 3
    • early shift and immune system: 1
    • early shift and SARS cov: 1, 2, 3, 4
    • host impair and immune response: 1, 2, 3, 4, 5, 6
    • host impair and immune system: 1
    • host impair and innate immunity: 1
    • host impair and SARS cov: 1, 2, 3, 4